Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 751 Jul 26 – Oct 23, 2026
- Disclosed funding
- $68.6B 606 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| BB BrainChild BioCompany profile BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma. BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma. | $116M | Series A | Biotech | United States | Investors Undisclosed | |
| TI Tokoshie, Inc.Company profile The developer of Ignite0, a conversational CAD tool that turns text and images into editable three-dimensional models. The developer of Ignite0, a conversational CAD tool that turns text and images into editable three-dimensional models. | Undisclosed | FundingUndisclosed | AI | United States | Investors | |
| P ParlayXCompany profile ParlayX provides institutional trading desks with a shared control and execution layer for prediction markets, including segregated capital, trader and bot permissions, non-custodial key management and order routing across venues. ParlayX provides institutional trading desks with a shared control and execution layer for prediction markets, including segregated capital, trader and bot permissions, non-custodial key management and order routing across venues. | $1.3M | Pre-SeedPre-seed | Fintech | United States | Investors | |
| GL Gimlet LabsCompany profile Provides a cloud inference platform and compiler that distribute AI workloads across different processor types. Provides a cloud inference platform and compiler that distribute AI workloads across different processor types. | $300M | Series B | AI | United States | Investors | |
| CB Cloverleaf BioCompany profile Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical. Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical. | $33M | Seed | Biotech | United States | Investors | |
| A AntiochCompany profile Cloud simulation software helps robotics and autonomy teams develop and test physical AI systems before deployment. Cloud simulation software helps robotics and autonomy teams develop and test physical AI systems before deployment. | $32M | Series A | AI | United States | Investors | |
| E EmberosCompany profile Emberos gives brands a system to track how AI assistants represent them, understand the sources and narratives behind those answers, and take and measure actions intended to improve their visibility and accuracy across AI platforms. Emberos gives brands a system to track how AI assistants represent them, understand the sources and narratives behind those answers, and take and measure actions intended to improve their visibility and accuracy across AI platforms. | $5.5M | Seed | Enterprise software | United States | Investors Undisclosed | |
| D DivergeITCompany profile DivergeIT provides managed IT and cybersecurity services to U.S. businesses, combining help-desk support and management of devices, networks and cloud systems with security monitoring and response. DivergeIT provides managed IT and cybersecurity services to U.S. businesses, combining help-desk support and management of devices, networks and cloud systems with security monitoring and response. | Undisclosed | Strategic investmentUndisclosed | Business services | United States | Investors | |
| C ChipMangoCompany profile ChipMango combines semiconductor engineering services with training for aspiring chip designers. Its learning platform provides industry-aligned courses, practical labs and access to professional electronic-design tools, while its engineers deliver design and verification work for commercial customers. ChipMango combines semiconductor engineering services with training for aspiring chip designers. Its learning platform provides industry-aligned courses, practical labs and access to professional electronic-design tools, while its engineers deliver design and verification work for commercial customers. | $1.9M | FundingUndisclosed | Hardware | United States | Investors | |
| S SunivaCompany profile Suniva manufactures silicon solar cells for module makers building US solar supply chains. Suniva manufactures silicon solar cells for module makers building US solar supply chains. | $835M | Debt and equity financingUndisclosed | Climate tech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 26, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Greptile
55rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
42rounds16led - 3Khosla Ventures
Arda Industries, Tolan
25rounds6led - 4Sequoia Capital
Warhound, Whop, Blacksmith
23rounds7led - 5Alumni Ventures
Maxinsights, Daytona, Chariot Claims
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.